You are here » Home » Companies » Company Overview » Parabolic Drugs Ltd

Parabolic Drugs Ltd.

BSE: 533211 Sector: Health care
NSE: PARABDRUGS ISIN Code: INE618H01016
BSE LIVE 15:46 | 06 Dec 8.84 0.50
(6.00%)
OPEN

8.12

HIGH

9.00

LOW

7.71

NSE LIVE 15:41 | 06 Dec 8.55 0.30
(3.64%)
OPEN

8.00

HIGH

8.80

LOW

8.00

OPEN 8.12
PREVIOUS CLOSE 8.34
VOLUME 35334
52-Week high 11.31
52-Week low 3.75
P/E
Mkt Cap.(Rs cr) 54.71
Buy Price 8.84
Buy Qty 779.00
Sell Price 0.00
Sell Qty 0.00
OPEN 8.12
CLOSE 8.34
VOLUME 35334
52-Week high 11.31
52-Week low 3.75
P/E
Mkt Cap.(Rs cr) 54.71
Buy Price 8.84
Buy Qty 779.00
Sell Price 0.00
Sell Qty 0.00

About Parabolic Drugs Ltd.

Parabolic Drugs Ltd

Parabolic Drugs Ltd is one of the fast growing API (Active Pharmaceutical Ingredients) and API intermediate manufacturing and marketing company. The company is in SME segment, with increasing international presence and a strong R&D foundation. The company is based in Chandigarh. They have one subsidiary company namely Parabolic Research Labs Ltd. The company produces the SSP and Cephalosporin r...> More

Parabolic Drugs Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   55
EPS - TTM () [*S] -
P/E Ratio (X) [*S] -
Face Value ()   10
Latest Dividend (%)   2.50
Latest Dividend Date 24 Sep 2012
Dividend Yield (%) 0.00
Book Value / Share () [*S] -133.74
P/B Ratio () [*S] -0.07
[*C] Consolidated     [*S] Standalone

Parabolic Drugs Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 16.41 19.73 -16.83
Other Income -
Total Income 16.41 19.73 -16.83
Total Expenses 16.27 77.96 -79.13
Operating Profit 0.14 -58.23 100.24
Net Profit -43.12 -101.86 57.67
Equity Capital 61.89 61.89 -
> More on Parabolic Drugs Ltd Financials Results

Parabolic Drugs Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Alpa Lab. 29.30 -4.09 61.65
Natural Capsules 92.90 -0.05 57.88
Bafna Pharma. 31.00 1.14 57.85
Parabolic Drugs 8.84 6.00 54.71
Panch.Organics 107.85 -4.09 54.14
Kilitch Drugs 37.25 0.68 49.28
Makers Labs. 96.95 6.77 47.70
> More on Parabolic Drugs Ltd Peer Group

Parabolic Drugs Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 38.65
Banks/FIs 2.02
FIIs 8.06
Insurance 0.00
Mutual Funds 0.00
Indian Public 36.75
Custodians 0.00
Other 14.52
> More on Parabolic Drugs Ltd Share Holding Pattern

Parabolic Drugs Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 24.86% 19.58% 0.00% 0.01%
1 Month 20.93% 16.33% -3.23% -3.45%
3 Month 47.33% 43.70% -8.92% -8.94%
6 Month 114.56% 108.54% -1.44% -0.71%
1 Year -6.85% -9.52% 2.94% 4.64%
3 Year 58.42% 58.33% 25.70% 30.08%

Parabolic Drugs Ltd - STOCK STRENGTH

Today's Low/High 7.71
9.00
Week Low/High 7.06
9.00
Month Low/High 5.80
9.00
YEAR Low/High 3.75
11.00
All TIME Low/High 3.39
79.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard